NEO-102 (NEONC Technologies)

N/A

Report date: 2022/12/29 11:27:21

Base Information

Drug NameNEO-102 (NEONC Technologies)
Drug Alias NameNEO-102 (NEONC Technologies)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation inhibitors
TargetsTubulin
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeonc Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeonc Technologies Inc
Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A